Alliance Pharma Plc (APH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
50
About the Report
About the Report
Summary
Alliance Pharma Plc (Alliance) is a specialty pharmaceutical company. It focuses on acquisition, licensing, registration and marketing of pharmaceutical products. It promotes acquired and licensed prescription products across various therapeutic categories such as dermatology, central nervous system, women's health, infectious disease, cardiovascular, respiratory, immunology, gastrointestinal, oncology, nutrition, toxicology and mouth and dental disorders. The company distributes its products through wholesalers, retail pharmacies, hospitals and international network of distributors. It operates in the UK, Ireland, British Virgin Islands, France and Germany. Alliance is headquartered in Chippenham, Wiltshire, the UK.
Alliance Pharma Plc (APH)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Alliance Pharma Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alliance Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Alliance Pharma Acquires Nizoral from Janssen Pharma for USD79.5 Million 11
Alliance Pharma Acquires Rights of Vamousse from TyraTech 12
Alliance Pharma Acquires Healthcare Products Business from Sinclair IS Pharma for USD198.4 Million 13
Alliance Pharma Acquires Rights of Nutraceutical Brands from Sinopharm Nutraceuticals for USD2.1 Million 14
Alliance Pharma Acquires Rights To Irenat From Bayer 15
Alliance Pharma Acquires Rights To Lypsyl From Novartis For USD 3 Million 16
Alliance Pharma Acquires Overseas Rights To Syntometrine From Novartis For USD 11.5 Million 17
Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For USD 8 Million 18
Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For USD 4 Million 19
Licensing Agreements 20
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 20
Equity Offering 21
Alliance Pharma Raises USD45 Million in Private Placement of Shares 21
Alliance Pharma Raises USD7.6 Million in Private Placement of Shares 22
Acquisition 23
Pacific Glory Development to Acquire 60% Stake in Unigreg for USD4 Million 23
Alliance Pharma Acquires MacuVision 24
Alliance Pharma Acquires Opus, Healthcare Products Distributor, For USD 15.3 Million 25
Alliance Pharma Plc-Key Competitors 26
Alliance Pharma Plc-Key Employees 27
Alliance Pharma Plc-Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Financial Announcements 30
Sep 19, 2018: Alliance Pharma announces interim results for the six months ended 30 June 2018 30
Jul 25, 2018: Alliance Pharma: half year trading update 37
Mar 27, 2018: APH Full Year Results 38
Mar 27, 2018: Alliance Pharma: Results for the year ended 31 December 2017 39
Sep 13, 2017: Alliance Pharma: Interim Results for the six months ended 30 June 2017 44
Jul 18, 2017: Alliance Pharma: Half Year Trading Update 45
Mar 29, 2017: Alliance Pharma: Results for the year ended 31 December 2016 46
Jan 23, 2017: Alliance Pharma Announces Pre-Close Trading Update 47
Corporate Communications 48
May 30, 2018: Alliance Pharma: Directorate Change 48
Mar 01, 2018: Alliance Pharma: Directorate Changes 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
List of Figure
List of Figures
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
List of Table
List of Tables
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alliance Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alliance Pharma Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alliance Pharma Acquires Nizoral from Janssen Pharma for USD79.5 Million 11
Alliance Pharma Acquires Rights of Vamousse from TyraTech 12
Alliance Pharma Acquires Healthcare Products Business from Sinclair IS Pharma for USD198.4 Million 13
Alliance Pharma Acquires Rights of Nutraceutical Brands from Sinopharm Nutraceuticals for USD2.1 Million 14
Alliance Pharma Acquires Rights To Irenat From Bayer 15
Alliance Pharma Acquires Rights To Lypsyl From Novartis For USD 3 Million 16
Alliance Pharma Acquires Overseas Rights To Syntometrine From Novartis For USD 11.5 Million 17
Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For USD 8 Million 18
Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For USD 4 Million 19
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 20
Alliance Pharma Raises USD45 Million in Private Placement of Shares 21
Alliance Pharma Raises USD7.6 Million in Private Placement of Shares 22
Pacific Glory Development to Acquire 60% Stake in Unigreg for USD4 Million 23
Alliance Pharma Acquires MacuVision 24
Alliance Pharma Acquires Opus, Healthcare Products Distributor, For USD 15.3 Million 25
Alliance Pharma Plc, Key Competitors 26
Alliance Pharma Plc, Key Employees 27
Alliance Pharma Plc, Subsidiaries 28
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.